Funded Project Details - FY2021
|Title:|| Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients|
|Congressional District Code:
||Clinical Science R&D
|| July 2021 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Rheumatoid arthritis (RA) is the most common inflammatory arthritis with a prevalence of around 0.6% in the general population and is a common chronic autoimmune disease in the veteran population. RA patients suffer greater mortality and morbidity from infectious diseases. This increased burden is in part related to the immune derangements of RA itself, and some of it is attributable to the immunosuppressive therapies that are used to treat RA. Herpes Zoster (HZ) reactivation is the most common...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.